Skip to main content
Equibles

Caption Management, LLC

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1706766 OKLAHOMA CITY, OK
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$588,704
-$2,268,904 QoQ
Shares Held
193,018
-69.6% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#39
of 163 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Derivatives in LRMR

reported options exposure · as of Mar 31, 2026
CallValue
$738,900
CallShares
164,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. LRMR ranks #51 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in LRMR

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $588,704 193,018
2026-03-31 $738,900 164,200
2026-03-31 $2,857,608 635,024
2025-12-31 $1,582,270 415,294
2025-09-30 $4,973,231 1,539,700
2025-09-30 $4,238,896 1,312,352
2025-06-30 $1,992,048 689,290
2025-06-30 $3,885,894 1,344,600
2024-12-31 $96,750 25,000
2024-03-31 $1,084,611 142,900
2024-03-31 $2,021,976 266,400